Roberto Grimaldi

Nessuna posizione attualmente

Health Technology

Consumer Services

Commercial Services

Profilo

Roberto Grimaldi worked as an Executive Vice President at Crucell Biologics, Inc. and as a Principal at Seqirus Vaccines Ltd., Sandoz Corp., and Mucosis BV.
He obtained an undergraduate degree from the University of Pavia.

Precedenti posizioni note di Roberto Grimaldi

Società	Posizione	Fine
Sandoz Corp. Sandoz Corp. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Sandoz Corp. develops, produces, and markets medicines.	Corporate Officer/Principal	-
Crucell Biologics, Inc. Crucell Biologics, Inc. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Crucell Biologics, Inc. is a company that manufactures and supplies biopharmaceutical products. The company is based in Miami, FL.	Corporate Officer/Principal	-
Seqirus Vaccines Ltd. Seqirus Vaccines Ltd. BiotechnologyHealth Technology Seqirus Vaccines Ltd. manufactures vaccines. The company is headquartered in Maidenhead, the United Kingdom.	Corporate Officer/Principal	-
Mucosis BV Mucosis BV Miscellaneous Commercial ServicesCommercial Services Mucosis BV develops mucosal vaccines for infectious diseases. Its product is SynGEM, an intranasal vaccine to prevent respiratory syncytial virus infection. Its vaccines are based on the patented and validated Mimopath technology. This technology enables a more natural immune response as well as a broad base of protection as was seen in the proof-of-concept animal and human studies of our FluGEM vaccine candidate. The company was founded by Cornelis Leenhouts in 2007 and is headquartered in Groningen, the Netherlands.	Direttore Tecnico/Scientifico/R&S	-

Vedi nel dettaglio l'esperienza di Roberto Grimaldi

Formazione di Roberto Grimaldi

University of Pavia

Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private